BioStock: Chordate installs system in Germany and launches in the UAE

Chordate Medical has secured an agreement for the installation of the migraine treatment Ozilia at a private specialist clinic in Germany. This follows from the active work of the company's marketing consultants who are introducing the treatment to the German market. In addition, Chordate Medical has recently contracted a market expert in the United Arab Emirates for introduction of the migraine and rhinitis treatment. CEO Anders Weilandt tells us more in an interview. 

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/chordate-installs-system-in-germany-and-launches-in-the-uae

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se